Impact of Pretransplantation 18F-fluorodeoxy Glucose–Positron Emission Tomography Status on Outcomes after Allogeneic Hematopoietic Cell Transplantation for Non-Hodgkin Lymphoma
Veronika Bachanová(University of Minnesota), Mehdi Hamadani(Medical College of Wisconsin), Tim Prestidge(Starship Children's Health), Sonali M. Smith(University of Chicago), Tanya Siddiqi(City Of Hope National Medical Center), Jonathon B. Cohen(Emory University), Siddhartha Ganguly(University of Kansas Medical Center), Maxim Norkin(Centre Hospitalier Universitaire Vaudois), Patrick J. Stiff(Loyola University Medical Center), David G. Maloney(Fred Hutch Cancer Center), Mohamed A. Kharfan‐Dabaja(Jacksonville College), Amanda F. Cashen(Washington University in St. Louis), Anita D’Souza, Hillard M. Lazarus(University Hospitals of Cleveland), César O. Freytes(CHRISTUS Transplant Institute), Reinhold Munker(Louisiana State University), Prakash Satwani(Pediatrics and Genetics), Philippe Armand(Harvard University), Alberto Mussetti(Duran i Reynals Hospital), Jeanette Carreras(Medical College of Wisconsin), Adriana K. Malone(Icahn School of Medicine at Mount Sinai), Taiga Nishihori(Moffitt Cancer Center), Basem M. William(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Baldeep Wirk(Boston University), Abraham S. Kanate(HonorHealth), Ginna G. Laport(Stanford Blood Center), David J. Inwards(Mayo Clinic), Samantha Jaglowski(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Nilanjan Ghosh(Levine Cancer Institute), Linda J. Burns(University of Minnesota System), Robert Peter Gale(Imperial College London), Görgün Akpek(Banner MD Anderson Cancer Center), Jacob M. Rowe(City Of Hope National Medical Center), Leona Holmberg(University of Washington), Anna M. Sureda(Institut Català d'Oncologia), Kwang Woo Ahn(Medical College of Wisconsin), Edward Agura(Baylor University), Mitchell S. Cairo(New York Medical College)
Cited by 41
Related Papers
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
|New England Journal of Medicine|2017|6k
PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
|New England Journal of Medicine|2014|3.5k
Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1–2 trial
|The Lancet Oncology|2018|2.3k
Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia
|New England Journal of Medicine|2012|1.9k
KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma
|New England Journal of Medicine|2020|1.9k